Case study
Prescription Medicine Launch Process in the UK
Gain crucial insights into launching prescription medicines in the UK with expert perspectives on NHS and pharmaceutical dynamics. BTHT facilitated one-hour consultations with top-tier professionals, including a Health Economics Director with NHS/NICE experience and the Head of Market Access at a leading UK pharmaceutical company. These expert discussions provided valuable understanding of market access, health economics, and regulatory challenges, enabling the consulting firm to effectively navigate the UK prescription medicine landscape and refine their business strategy.
- Europe
- UK
- Pharma
CHALLENGE
A leading strategy consultancy faced a challenge: comprehending the intricacies of launching prescription medicines in the United Kingdom. Their curiosity led them to approach this matter from dual perspectives - scrutinizing the National Health Service (NHS) side and the pharmaceutical aspect. Opting to utilize BTHT's proficiency in exploring specialized and elusive subjects, the consultancy aimed to tap into expertise on both ends of the spectrum.
BTHT APPROACH
The BTHT team delved into the intricacies of the project, meticulously deciphering the requirements and objectives at hand. Keen on delivering swift and effective results, team members embarked on an extensive research journey. The mission of the research team was unravelling the intricacies of the healthcare landscape, exploring prevalence, trends, challenges, and key players. The team engaged with professionals who have market access/launch experience from NHS/NICE and private sector.
Among the expert profiles handpicked by BTHT were: - A current Health Economics Director at a pharmaceutical company, with a notable stint as a former Director and Committee Member at NHS/NICE. - The current Head of Market Access at a leading pharmaceutical company in the UK.
The team arranged the 1 hour consultations promptly and managed the process smoothly, ensuring that no problems arose.
OUTCOME
BTHT enabled the consultancy firm to seamlessly engage with highly qualified NHS/private sector experts who are specialized in market access/health economics. This collaboration yielded essential insights that proved instrumental in advancing their strategic project objectives. Empowered by this newfound understanding, our client adeptly navigated the landscape of prescription medicine launches in the UK, strategically shaping their business plan to harmonize with the unique intricacies of the market.
Let's talk about your project
Reach our CEO Alexis Capelle directly or send us a message — we typically reply within one business day.